Two companies control more than 70 percent of U.S. corn and soybean seed sales. The top four cottonseed companies own nearly 94 percent of that market. Those aren’t new numbers—the USDA documented them in a May 2026 court filing in a legal dispute between two major seed companies. But the consolidation they reveal is a quiet crisis in American agriculture, and it’s being bankrolled by the very people it’s locking out: taxpayers and farmers.
The Monopoly, Numbered
Seed consolidation didn’t happen overnight. Over the past two decades, the industry collapsed from dozens of regional breeding programs into a handful of global players. Monsanto merged with Bayer. Dow and DuPont fused into Corteva. Syngenta consolidated under ChemChina. In cotton, the math is even starker: four companies now own 94 percent of the cottonseed market. That’s not competition. That’s a bottleneck.
Farmers are paying the cost. When you can’t choose between seed suppliers because only a handful exist, prices don’t drop. They climb. Farmers buy what’s available, not what works best for their soil or their operation. And those companies aren’t selling seeds—they’re selling proprietary genetics locked behind patents that prevent farmers from saving, replanting, or even studying the genetics they’re buying.
The Patent Trap
Patents on seeds do something older agricultural monopolies couldn’t: they make it illegal to do what farmers have done for 10,000 years. You can’t save seed from this year’s crop and plant it next year. You can’t share seed with your neighbor. You can’t breed around a genetic bottleneck by mixing varieties. The law—the Plant Patent Act and utility patents on plant genetics—makes all of that infringement.
The theory was supposed to incentivize breeding innovation. Companies invest in crop improvement, get patent protection, recover their R&D costs, and everyone benefits from better crops. That might work in a competitive market. In a four-company cottonseed cartel, it’s just rent extraction.
Farmers end up locked into annual seed purchases of whatever the cartel is selling. If those seeds don’t adapt well to your climate or soil type, you’re not choosing a competitor—you’re buying again from the same company, or you’re planting a marginal variety that doesn’t optimize your yield. That’s how consolidation concentrates risk into fewer hands.
The Taxpayer Subsidy
Here’s the part that should anger every farmer and every taxpayer: the innovation those patents lock was partly funded by the public. Land-grant universities—funded by state appropriations and federal grants—have been developing crop genetics for over a century. That public investment built the breeding infrastructure, the germplasm repositories, the knowledge base that modern seed companies rely on. And then those companies patent the results and sell them back to farmers.
The USDA funds breeding programs. NSF funds crop genetics research. Universities license germplasm to seed companies. And then those companies use patents to prevent the same public that funded the research from using or improving the genetics. The profit is private. The risk and initial investment were public.
Some land-grant universities still breed and sell seed through their extension systems. But as consolidation accelerated, the public breeding programs got starved. Why fund a competitive seed program when private companies can lobby for patent protection stronger than anything the public sector could compete with? The result: the industry consolidated, the public programs withered, and now farmers and taxpayers are both locked out.
Where It Locks Down Further
Patent protection isn’t the only trap. Seed companies also bundle patents with digital rights management. Some hybrid seeds are genetically sterile—they produce a crop but not viable seed for next year. Some varieties are engineered to respond only to specific fertilizer regimens from the same company. This isn’t accidental. It’s a business model: force farmers into annual purchases, annual inputs, annual lock-in.
And if a farmer or researcher tries to study the genetics to understand what they’re buying, the Digital Millennium Copyright Act makes that illegal too. You can’t reverse-engineer a seed variety to see what’s in it. You can’t publish research on a patented crop variety without risking a lawsuit. The seed companies own not just the genetics but the knowledge about them.
What Consolidation Costs
Farmers in competitive markets buy the best seed for their operation at the lowest price. Farmers in a cartel buy what’s available, at the price the cartel sets. The result is higher input costs, less crop diversity, and less resilience. If a weather event favors one genetic background, farmers using that company’s seed all suffer together. If a disease emerges that a patented variety isn’t resistant to, farmers can’t quickly breed around it—the germplasm is patented, the expertise is concentrated, and the consolidation means there’s no second option.
Smaller seed companies that used to compete in regional markets got bought or went out of business. Young farmers trying to start breeding programs can’t access germplasm without signing licensing agreements that let corporations dictate what they can do with it. The barriers to entry that consolidation creates lock out the next generation of farmers and breeders.
And taxpayers keep funding the research that private companies lock up behind patents. It’s a transfer payment to corporate shareholders dressed up as agricultural innovation.
What Comes Next
The USDA filed that May 2026 court brief in a private dispute, not to solve consolidation—just to clarify a technical point about plant variety protection. Antitrust agencies haven’t seriously challenged seed industry consolidation in decades. Congress subsidizes crop production without requiring public access to the genetics they’re funding. And farmers keep buying seed from the same four companies, paying prices set by a cartel, unable to save seed or breed their own.
Breaking the consolidation would require Congress to reform patent law, fund competing public breeding programs, and allow farmer-led seed sharing and breeding. Barring that, the status quo continues: farmers pay more for less choice, taxpayers fund the monopoly that locks them out, and the seed industry extracts profit from both.
The fight for seed diversity and farmer autonomy used to be about access to better genetics. Now it’s about getting access to genetics at all.
Sources: Civil Eats — “How Everyone Pays the Cost for Patents on Seeds” (USDA May 2026 court filing on seed market consolidation); USDA Economic Research Service; U.S. plant patent and utility patent law (Patent Act, Plant Variety Protection Act); land-grant university agricultural extension records.
